findmyKOL
Clinical trialNCT04159519CompletedPhase 4Interventional

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

SponsorAstraZenecaEnrollment170AsthmaSevere Eosinophilic Asthma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Research Site

    Brest, France

  • Research Site

    Dijon, France

  • Research Site

    Le Kremlin-Bicêtre, France

  • Research Site

    Lille, France

  • Research Site

    Lyon, France

  • Research Site

    Pessac, France

Germany
  • Research Site

    Berlin, Germany

  • Research Site

    Bonn, Germany

  • Research Site

    Cottbus, Germany

  • Research Site

    Hamburg, Germany

  • Research Site

    Hamburg, Germany

  • Research Site

    Hanover, Germany

  • Research Site

    Jena, Germany

  • Research Site

    Mainz, Germany

  • Research Site

    Marburg, Germany

  • Research Site

    München, Germany

Italy
  • Research Site

    Bergamo, Italy

  • Research Site

    Naples, Italy

  • Research Site

    Roma, Italy

United Kingdom
  • Research Site

    Belfast, United Kingdom

  • Research Site

    Cambridge, United Kingdom

  • Research Site

    London, United Kingdom

  • Research Site

    Nottingham, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Jul 2020
Primary completion
31 Jan 2023
Completion
31 Jan 2023
Last update posted
9 Jan 2025
Registered enrollment
170
Registry id
NCT04159519

Cross-registrations

EU-CTR / CTIS (EudraCT)2019-001924-37

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.